By Mark Watkins
Mazor Robotics Ltd – (NASDAQ:MZOR) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Monday, AnalystRatings.NET reports. The brokerage presently has a $10.00 price target on the stock. Zacks Investment Research‘s price objective would suggest a potential upside of 12.49% from the company’s previous close.
According to Zacks, “Mazor Robotics Ltd. is engaged in the development, production and marketing of medical devices for surgical procedures in the fields of orthopedics and neurosurgery. It offers Renaissance(TM), a surgical robotic system to conduct spine surgeries with less radiation. The company operates in the United States, Eastern Europe, Western Europe and Asia. Mazor Robotics Ltd. is based in Caesarea, Israel. “ 
Other equities research analysts have also recently issued research reports about the company. Needham & Company LLC reiterated a “hold” rating on shares of Mazor Robotics Ltd – in a research note on Thursday, November 5th. Sterne Agee CRT upgraded Mazor Robotics Ltd – from a “neutral” rating to a “buy” rating in a research note on Friday, November 20th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $13.00.